Pennant PE Ratio 2018-2026 | PNTG
Current and historical p/e ratio for Pennant (PNTG) from 2018 to 2026. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Pennant PE ratio as of September 16, 2026 is 36.34.
| Pennant PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-09-16 | 42.48 | 46.68 | |
| 2026-06-30 | 36.95 | $0.91 | 40.60 |
| 2026-03-31 | 30.48 | $0.86 | 35.44 |
| 2025-12-31 | 28.15 | $0.84 | 33.51 |
| 2025-09-30 | 25.22 | $0.75 | 33.63 |
| 2025-06-30 | 29.85 | $0.78 | 38.27 |
| 2025-03-31 | 25.15 | $0.76 | 33.09 |
| 2024-12-31 | 26.52 | $0.70 | 37.89 |
| 2024-09-30 | 35.70 | $0.68 | 52.50 |
| 2024-06-30 | 23.19 | $0.63 | 36.81 |
| 2024-03-31 | 19.63 | $0.54 | 36.35 |
| 2023-12-31 | 13.92 | $0.44 | 31.64 |
| 2023-09-30 | 11.13 | $0.42 | 26.50 |
| 2023-06-30 | 12.28 | $0.43 | 28.56 |
| 2023-03-31 | 14.28 | $0.25 | 57.12 |
| 2022-12-31 | 10.98 | $0.22 | 49.91 |
| 2022-09-30 | 10.41 | $0.03 | 347.00 |
| 2022-06-30 | 12.81 | $-0.09 | 0.00 |
| 2022-03-31 | 18.63 | $0.09 | 207.00 |
| 2021-12-31 | 23.08 | $0.09 | 256.44 |
| 2021-09-30 | 28.09 | $0.28 | 100.32 |
| 2021-06-30 | 40.90 | $0.39 | 104.87 |
| 2021-03-31 | 45.80 | $0.45 | 101.78 |
| 2020-12-31 | 58.06 | $0.52 | 111.65 |
| 2020-09-30 | 38.56 | $0.27 | 142.81 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $1.396B | $0.948B |
| The Pennant Group Inc. through subsidiaries offers home health, hospice and senior living services. It operates primarily in Arizona, California, Colorado, Idaho, Iowa, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. The Pennant Group Inc. is based in Eagle, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Elanco Animal Health (ELAN) | United States | $11.491B | 21.70 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Astrana Health (ASTH) | United States | $2.138B | 22.69 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |